Biocryst Pharmaceuticals (BCRX) EBT: 2010-2015
Historic EBT for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -$14.3 million.
- Biocryst Pharmaceuticals' EBT fell 11.36% to -$14.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$42.2 million, marking a year-over-year decrease of 0.88%. This contributed to the annual value of -$50.7 million for FY2014, which is 43.14% down from last year.
- As of Q3 2015, Biocryst Pharmaceuticals' EBT stood at -$14.3 million, which was down 443.67% from $4.2 million recorded in Q2 2015.
- In the past 5 years, Biocryst Pharmaceuticals' EBT ranged from a high of $4.2 million in Q2 2015 and a low of -$16.4 million during Q4 2014.
- Over the past 3 years, Biocryst Pharmaceuticals' median EBT value was -$12.8 million (recorded in 2014), while the average stood at -$10.2 million.
- Per our database at Business Quant, Biocryst Pharmaceuticals' EBT crashed by 117.43% in 2014 and then soared by 132.37% in 2015.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' EBT stood at -$12.1 million in 2011, then rose by 3.47% to -$11.3 million in 2012, then dropped by 17.79% to -$7.6 million in 2013, then plummeted by 117.43% to -$16.4 million in 2014, then fell by 11.36% to -$14.3 million in 2015.
- Its last three reported values are -$14.3 million in Q3 2015, $4.2 million for Q2 2015, and -$15.6 million during Q1 2015.